Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain (original) (raw)
Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach
Maureen Twiddy
Journal of Antimicrobial Chemotherapy, 2017
View PDFchevron_right
Budget impact analysis of two pharmaceutical management models in relation to the administration of intravenous anti-infective therapy in a Spanish nursing home
Francisco J Otero Espinar
European Journal of Hospital Pharmacy, 2019
View PDFchevron_right
Safety, Efficacy and Direct/Indirect Cost Analysis of Outpatient Antimicrobial Therapy Unit: Prospective Cohort Study from Turkey
Aliye Baştuğ
Mediterranean journal of infection, microbes & antimicrobials, 2023
View PDFchevron_right
Clinical benefits and costs of an outpatient parenteral antimicrobial therapy service
Sara Bugeja
Research in Social and Administrative Pharmacy, 2021
View PDFchevron_right
Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective
Andrew Lilly
Journal of Antimicrobial Chemotherapy, 2009
View PDFchevron_right
Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program
marcos pajaron
Hospital Practice
View PDFchevron_right
A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective
Dale Fisher
International Journal of Antimicrobial Agents, 2009
View PDFchevron_right
OPAT: proof of concept in a peripheral Belgian hospital after review of the literature
Christophe Indevuyst
Acta clinica Belgica, 2018
View PDFchevron_right
Hospital in the home is cost saving for appropriately selected patients: a comparison with in-hospital care
Zahid Ansari
International Journal for Quality in Health Care, 2002
View PDFchevron_right
Outpatient Intravenous Antibiotic Therapy: Reduces economic burden of patients
Dr suman akula
View PDFchevron_right
Importance of nondrug costs of intravenous antibiotic therapy
Peter Engelfriet
Critical care (London, England), 2003
View PDFchevron_right
Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program
Annette Schuermans
Infection, 2020
View PDFchevron_right
The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy
Kate McLintock, C. Czoski-Murray, Judy M Wright, Maureen Twiddy
View PDFchevron_right
Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison
Silvana Noviello
International Journal of Antimicrobial Agents, 2004
View PDFchevron_right
Economic Impact of an Antimicrobial Stewardship Program Implementation in Three High-Complexity Hospitals in Colombia
Cristhian Hernández-Gómez
Open Forum Infectious Diseases, 2016
View PDFchevron_right
Annual Antibiotic Related Economic Burden of Healthcare Associated Infections; a Cross-Sectional Population Based Study
Abdolrazagh marzban
Iranian Journal of Pharmaceutical Research, 2016
View PDFchevron_right
Cost analysis of hospital-at-home services vs. in-patient medical wards
shachaf shiber
View PDFchevron_right
Economic evaluation of the NSW hospital in the home pilot project, CHERE Project Report No 15
Marian Shanahan
2001
View PDFchevron_right
Costs of Medically Attended Acute Gastrointestinal Infections: The Polish Prospective Healthcare Utilization Survey
Marcin Czech
Value in Health Regional Issues, 2013
View PDFchevron_right
Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial
Jeremy Jones
BMJ, 1999
View PDFchevron_right
Executive summary of outpatient parenteral antimicrobial therapy: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society
Miriam Vicente
Enfermedades infecciosas y microbiologia clinica, 2018
View PDFchevron_right
Cost evaluation in adult ICU: α two-year study in a Greek State Hospital
Sotiria Koutsouki
Health & Research Journal, 2021
View PDFchevron_right
Additional cost of hospital-acquired infection to the patient: a case study in Turkey
Afsun Ezel Esatoğlu
Health Services Management Research, 2006
View PDFchevron_right
Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries: Applying a Standardized Costing Methodology
Peter Spronk
Value in Health, 2012
View PDFchevron_right
Patient level cost in secondary hospital oamjms 10e 1723
Asim Mehmood
2022
View PDFchevron_right
The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis
sandra guzman
American Journal of Infection Control, 2003
View PDFchevron_right
Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting
Vesna Mioljevic
Antimicrobial Resistance and Infection Control, 2023
View PDFchevron_right
Hospital-in-the-Home Treatment of Surgical Infectious Diseases: An Economic Analysis
Manuel Vallejo
Surgical Infections, 2007
View PDFchevron_right
An implementation on the social cost of hospital acquired infections
nurullah kurutkan
International journal of clinical and experimental medicine, 2015
View PDFchevron_right
Attributable Cost and Length of Stay for Patients With Central Venous Catheter–Associated Bloodstream Infection in Mexico City Intensive Care Units: A Prospective, Matched Analysis •
Nicholas Graves
Infection Control and Hospital Epidemiology, 2007
View PDFchevron_right
Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable
Juergen Klenk
ClinicoEconomics and Outcomes Research, 2016
View PDFchevron_right
Clinical outcomes and economic variables in critically ill patients with bloodstream infections
Dimitrios Zikos
Health Science Journal, 2014
View PDFchevron_right
Cost-Effectiveness Analysis of the Treatment of Ventilator-Associated Pneumonia with Linezolid or Vancomycin in Spain
Francisco Alvarez-Lerma
Journal of chemotherapy (Florence, Italy)
View PDFchevron_right